Investing.com - Zealand Pharma ADR reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Zealand Pharma ADR announced earnings per share of $-1.08 on revenue of $13.31M. Analysts polled by Investing.com anticipated EPS of $-0.9682 on revenue of $9.9M.
Zealand Pharma ADR shares are down 22.15% from the beginning of the year and are trading at $27.98 , down-from-52-week-high.They are under-performing the Nasdaq which is up 14.67% from the start of the year.
Zealand Pharma ADR shares lost 3.45% in intra-day trade following the report.
Zealand Pharma ADR follows other major Healthcare sector earnings this month
Zealand Pharma ADR's report follows an earnings beat by Merck ADR on Thursday, August 5, 2021, who reported EPS of $0.5304 on revenue of $5.77B, compared to forecasts EPS of $0.4897 on revenue of $5.63B.
Hoya Corp had beat expectations on Thursday, July 29, 2021 with second quarter EPS of $1.02 on revenue of $1.44B, compared to forecast for EPS of $0.8576 on revenue of $1.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar